Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

August 31, 2024

Conditions
Pharmacokinetics
Interventions
DRUG

MG-K10 humanized monoclonal antibody injection (prefilled syringe)

MG-K10 Humanized Monoclonal Antibody Injection

DRUG

MG-K10 humanized monoclonal antibody injection(Penicillin bottle)

MG-K10 humanized monoclonal antibody injection (single injection)

Trial Locations (1)

230061

The Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors
collaborator

The Second Hospital of Anhui Medical University

OTHER

lead

Shanghai Mabgeek Biotech.Co.Ltd

OTHER_GOV

NCT06277284 - Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter